In this episode of Pearls & Perspectives, host Amy Pearlman, MD, is joined by renowned male reproductive specialists Larry I. Lipshultz, MD, and Dolores J. Lamb, PhD, to discuss the science, clinical value, and future of the male infertility laboratory. Drawing on decades of collaboration in reproductive medicine, the conversation highlights the critical role of high-quality andrology laboratories in the evaluation of male infertility and explores how laboratory innovation has shaped clinical practice. Beyond the technical aspects of semen analysis, the discussion emphasizes the importance of close collaboration between laboratory scientists and clinicians to improve diagnostic accuracy and patient care.
The conversation examines the continued central role of the semen analysis while underscoring its limitations and the importance of proper specimen collection. Lamb outlines common pitfalls—including inadequate abstinence periods, incomplete sample collection, and improper handling—that can significantly affect results. The experts also weigh the growing popularity of at-home and mail-in semen testing, acknowledging that while these tools may encourage men to seek evaluation, challenges related to specimen quality, temperature fluctuations during shipping, chain of custody, and interpretation can limit their reliability. They stress that comprehensive evaluation by a reproductive urologist remains essential, particularly for fertility preservation before cancer treatment.
Pearlman, Lipshultz, and Lamb also explore the growing recognition of male infertility as a broad marker of men's health. They discuss evidence linking impaired fertility with an increased risk of systemic diseases, including cancer, and explain how abnormalities in spermatogenesis may reflect underlying genetic and biologic processes. The conversation highlights the need for greater awareness among both clinicians and patients that infertility evaluations can provide insights extending well beyond reproductive potential.
Looking toward the future, the group discusses emerging genetic and molecular approaches that could fundamentally reshape male infertility diagnostics. Lamb reflects on her pioneering work in sperm aneuploidy testing and argues that advances in genetics, artificial intelligence, and other emerging technologies may eventually move the field beyond reliance on conventional semen parameters alone. Although questions remain regarding cost, accessibility, and clinical implementation, the experts envision a future in which genetic and molecular profiling becomes an increasingly important component of routine male fertility evaluation, offering more precise diagnoses and better-informed reproductive counseling.
By Nelson Vergel | B.S. Chemical Engineering, MBA | Founder, ExcelMale.com | 34+ years on TRT | NIH and FDA advisory panel service | Author: Testosterone: A Man's Guide, Beyond Testosterone, The Peptide Consensus
Updated July 2026
Mail-in semen analysis has exploded in popularity because it solves a real problem: producing a sample in a cold clinic room is awkward, and plenty of men skip fertility testing entirely to avoid it. The kits get men tested who would otherwise never walk in. That access is worth something. The question is whether the number you get back means what you think it means.
Dr. Dolores Lamb, a PhD andrology lab director who ran a world-class infertility lab with Dr. Larry Lipshultz for 25 years, put it plainly in a recent discussion: collection problems are far more common than most men expect, and no one tells you about them. She said she could write a book on how men mishandle the sample. That gap in instruction, more than the shipping itself, is where mail-in results go wrong.
The honest answer is: it depends on what you are measuring and which kit you use. Sperm concentration holds up well. Motility does not.
A 2024 validation study published in F&S Reports compared split semen samples analyzed at under one hour against the same samples analyzed at 26 hours. Concentration and morphology showed high concordance. Even in real-world shipping conditions, the mail-in method was less variable than the differences seen between separate labs on standard proficiency testing (Nelson et al., 2024). That is a meaningful finding, because it says a good mail-in kit can be more consistent than sending your sample to two different clinics.
But motility is fragile. A 2025 study using an at-home collection kit tracked the same samples across five time points and found total and progressive motility dropped, with the steepest decline after six hours (Alexander et al., 2025). Sperm are alive. The longer they sit in transit, the more of them stop moving.
Here is where it gets more complicated. Many mail-in services apply a correction algorithm that estimates what your motility "should have been" at the one-hour mark, adjusting for the hours the sample spent in the mail. A 2026 analysis of nearly 47,000 mail-in tests presented at the ESHRE annual meeting argued that these algorithmic corrections can overfit, and that for roughly one in ten men the adjusted number could push them across a clinical decision threshold in the wrong direction (Pomeroy et al., 2026). In plain terms: the software fixing a degraded sample might tell a fertile man he has a problem, or the reverse.
Total motile sperm count (TMSC) is the number that matters most for natural conception. It combines volume, concentration, and motility into a single figure. Because it depends on motility, it inherits motility's shipping problem. A TMSC above 20 million is generally reassuring; below that, the odds start dropping. If your mail-in TMSC comes back low, that is a reason to confirm in a clinic, not a diagnosis.
Most bad results trace back to the collection, not the sperm. These are the mistakes Lamb flagged, and they apply whether you test at home or in a clinic.
Abstinence period. You need to abstain from ejaculation for two to seven days before collecting. The WHO settled on this window because it balances volume and motility (Barbagallo et al., 2025). Collect too soon and your volume and count drop. Wait too long and motility falls while DNA fragmentation climbs. A cross-sectional study of 3,052 men found both short and long abstinence dragged down sperm quality, with the two-to-seven-day window giving the most reliable numbers (Hu et al., 2022). Men doing mail-in tests routinely get this wrong because the instruction is buried in the paperwork.
Incomplete collection. The first fraction of the ejaculate carries most of the sperm. Miss it, spill it, or lose it, and you will read as low-count when your actual count is fine. Lamb noted that clinics used to have patients sign a form confirming they collected the whole sample, because partial collections were common enough to matter. At home, no one is checking.
Timing for shipping. Mail-in kits are meant to be collected in time for the last pickup, so the sample ships fast. Men collect first thing in the morning before work, or the night before, and the sample sits for hours before it even enters the mail. Every hour costs motility.
Temperature. Once your package is moving, you lose control. It rides in trucks with no climate control, sits on tarmacs, waits in sorting facilities. Lamb described asking shippers about the journey and learning how many temperature swings a package goes through. Preservation media buffer some of this, but heat and cold both kill sperm, and the decline is not linear across men. Some samples crash within hours; others hold up. You cannot know in advance which you have.
Semen parameters swing a lot within the same man from sample to sample. That variability is biological, not a lab error. A febrile illness, a rough stretch of sleep, or a hot bath two months earlier can all show up in a single count, because the sperm being ejaculated today started forming about 70 days ago. This is why urologists never diagnose off one test. If a result concerns you, repeat it after a few weeks under clean conditions before drawing any conclusion.
At-home testing is a screening tool. It is good at getting you into the system and giving you a rough read. It is not the right choice for every situation.
Go to a clinic when the stakes are high. Fertility preservation before cancer treatment is the clearest case. If you are about to start chemotherapy, that stored sample may be your only future chance at biological children, and men in this situation often already have poor parameters because of the illness itself. Lamb was blunt about this: travel to bank your sperm, do not mail it. A mail-in kit cannot guarantee chain of custody, and years later, when you go to use a banked sample, you want certainty that the vial with your name on it is actually yours.
Go to a clinic when your mail-in result is abnormal. A low count or low TMSC from a shipped sample needs confirmation before it drives any treatment decision, especially given the algorithmic-correction concerns above.
A clinic is also the answer when you need parameters a home kit cannot measure. Standard mail-in tests report count, motility, and morphology. They do not assess sperm DNA fragmentation, anti-sperm antibodies, or the genetic factors a reproductive urologist can order. If you have been trying to conceive without success and your basic numbers look normal, those deeper tests are where the answer often lives.
That said, at-home testing has a genuine place. It works for post-vasectomy checks, where you mostly want to confirm the count is at or near zero and convenience improves compliance. It works as a first look for a man who would otherwise avoid the topic. And in rural areas with no urologist for hours in any direction, a mail-in kit may be the only realistic option. The wives, Lipshultz noted, often love the phone-based kits, because they get their partners engaged in the process at all. Getting tested imperfectly beats not getting tested.
This is the part most men miss. Your semen analysis is not only a fertility test. It is one of the few routine windows into your long-term health, and the connection is strong enough that it should change how you think about the result.
Men with impaired semen quality carry a higher risk of a range of conditions, including cancer, cardiovascular and metabolic disease, and autoimmune disorders (Chen et al., 2022). A 2014 study in Human Reproduction, co-authored by Lamb and Lipshultz, followed men after infertility evaluation and found those with abnormal semen parameters had a higher risk of death in the following years, a link that held even after accounting for baseline health (Eisenberg et al., 2014). The relationship is dose-dependent: the more parameters that are abnormal, the steeper the risk.
The likely reason is that sperm production is biologically demanding and sensitive. The same processes that go wrong in the testis, mistakes in DNA replication and repair, can show up elsewhere in the body. Lamb described infertile men as sometimes carrying a "mutator phenotype," a tendency toward DNA copying errors that the testis is good at catching but other tissues are not.
So a low number is worth taking seriously beyond the immediate question of fatherhood. It is a prompt to look at the rest of your health. A 2024 review framed the male fertility evaluation as an opportunity to catch metabolic and cardiovascular problems early, while a man is still young enough to change the trajectory (Del Giudice et al., 2024). For men on TRT thinking about coming off to conceive, this is one more reason to treat the semen analysis as a real clinical checkpoint, not a box to tick.
One detail rarely makes it into the pitch for at-home kits: the sample you mail is a snapshot of what your body was doing about ten weeks ago, not today. Sperm take roughly 70 days to form, so a rough patch last winter can show up in this month's result long after you have recovered. That lag is exactly why a single number, mailed or in-clinic, is a starting point rather than a verdict. Use the mail-in test to get on the board, then confirm anything worrying with a urologist who can watch the trend and order what a kit cannot.
If you are on TRT and planning for fertility, the hCG and testicular protection guide is the next thing worth reading.
ExcelMale.com is one of the largest men's health communities online, with over 24,000 members and more than 20 years of archived discussions on testosterone replacement therapy, hormone optimization, fertility, and men's health. It was founded by Nelson Vergel, a chemical engineer, longtime patient advocate, and author of Testosterone: A Man's Guide and Beyond Testosterone.
The conversation examines the continued central role of the semen analysis while underscoring its limitations and the importance of proper specimen collection. Lamb outlines common pitfalls—including inadequate abstinence periods, incomplete sample collection, and improper handling—that can significantly affect results. The experts also weigh the growing popularity of at-home and mail-in semen testing, acknowledging that while these tools may encourage men to seek evaluation, challenges related to specimen quality, temperature fluctuations during shipping, chain of custody, and interpretation can limit their reliability. They stress that comprehensive evaluation by a reproductive urologist remains essential, particularly for fertility preservation before cancer treatment.
Pearlman, Lipshultz, and Lamb also explore the growing recognition of male infertility as a broad marker of men's health. They discuss evidence linking impaired fertility with an increased risk of systemic diseases, including cancer, and explain how abnormalities in spermatogenesis may reflect underlying genetic and biologic processes. The conversation highlights the need for greater awareness among both clinicians and patients that infertility evaluations can provide insights extending well beyond reproductive potential.
Looking toward the future, the group discusses emerging genetic and molecular approaches that could fundamentally reshape male infertility diagnostics. Lamb reflects on her pioneering work in sperm aneuploidy testing and argues that advances in genetics, artificial intelligence, and other emerging technologies may eventually move the field beyond reliance on conventional semen parameters alone. Although questions remain regarding cost, accessibility, and clinical implementation, the experts envision a future in which genetic and molecular profiling becomes an increasingly important component of routine male fertility evaluation, offering more precise diagnoses and better-informed reproductive counseling.
By Nelson Vergel | B.S. Chemical Engineering, MBA | Founder, ExcelMale.com | 34+ years on TRT | NIH and FDA advisory panel service | Author: Testosterone: A Man's Guide, Beyond Testosterone, The Peptide Consensus
Updated July 2026
Mail-in semen analysis has exploded in popularity because it solves a real problem: producing a sample in a cold clinic room is awkward, and plenty of men skip fertility testing entirely to avoid it. The kits get men tested who would otherwise never walk in. That access is worth something. The question is whether the number you get back means what you think it means.
Dr. Dolores Lamb, a PhD andrology lab director who ran a world-class infertility lab with Dr. Larry Lipshultz for 25 years, put it plainly in a recent discussion: collection problems are far more common than most men expect, and no one tells you about them. She said she could write a book on how men mishandle the sample. That gap in instruction, more than the shipping itself, is where mail-in results go wrong.
Are Mail-In Semen Tests Accurate?
The honest answer is: it depends on what you are measuring and which kit you use. Sperm concentration holds up well. Motility does not.
A 2024 validation study published in F&S Reports compared split semen samples analyzed at under one hour against the same samples analyzed at 26 hours. Concentration and morphology showed high concordance. Even in real-world shipping conditions, the mail-in method was less variable than the differences seen between separate labs on standard proficiency testing (Nelson et al., 2024). That is a meaningful finding, because it says a good mail-in kit can be more consistent than sending your sample to two different clinics.
But motility is fragile. A 2025 study using an at-home collection kit tracked the same samples across five time points and found total and progressive motility dropped, with the steepest decline after six hours (Alexander et al., 2025). Sperm are alive. The longer they sit in transit, the more of them stop moving.
Here is where it gets more complicated. Many mail-in services apply a correction algorithm that estimates what your motility "should have been" at the one-hour mark, adjusting for the hours the sample spent in the mail. A 2026 analysis of nearly 47,000 mail-in tests presented at the ESHRE annual meeting argued that these algorithmic corrections can overfit, and that for roughly one in ten men the adjusted number could push them across a clinical decision threshold in the wrong direction (Pomeroy et al., 2026). In plain terms: the software fixing a degraded sample might tell a fertile man he has a problem, or the reverse.
Total motile sperm count (TMSC) is the number that matters most for natural conception. It combines volume, concentration, and motility into a single figure. Because it depends on motility, it inherits motility's shipping problem. A TMSC above 20 million is generally reassuring; below that, the odds start dropping. If your mail-in TMSC comes back low, that is a reason to confirm in a clinic, not a diagnosis.
What Ruins a Semen Sample Before the Lab Ever Sees It?
Most bad results trace back to the collection, not the sperm. These are the mistakes Lamb flagged, and they apply whether you test at home or in a clinic.
Abstinence period. You need to abstain from ejaculation for two to seven days before collecting. The WHO settled on this window because it balances volume and motility (Barbagallo et al., 2025). Collect too soon and your volume and count drop. Wait too long and motility falls while DNA fragmentation climbs. A cross-sectional study of 3,052 men found both short and long abstinence dragged down sperm quality, with the two-to-seven-day window giving the most reliable numbers (Hu et al., 2022). Men doing mail-in tests routinely get this wrong because the instruction is buried in the paperwork.
Incomplete collection. The first fraction of the ejaculate carries most of the sperm. Miss it, spill it, or lose it, and you will read as low-count when your actual count is fine. Lamb noted that clinics used to have patients sign a form confirming they collected the whole sample, because partial collections were common enough to matter. At home, no one is checking.
Timing for shipping. Mail-in kits are meant to be collected in time for the last pickup, so the sample ships fast. Men collect first thing in the morning before work, or the night before, and the sample sits for hours before it even enters the mail. Every hour costs motility.
Temperature. Once your package is moving, you lose control. It rides in trucks with no climate control, sits on tarmacs, waits in sorting facilities. Lamb described asking shippers about the journey and learning how many temperature swings a package goes through. Preservation media buffer some of this, but heat and cold both kill sperm, and the decline is not linear across men. Some samples crash within hours; others hold up. You cannot know in advance which you have.
Why Does One Bad Result Not Mean You Are Infertile?
Semen parameters swing a lot within the same man from sample to sample. That variability is biological, not a lab error. A febrile illness, a rough stretch of sleep, or a hot bath two months earlier can all show up in a single count, because the sperm being ejaculated today started forming about 70 days ago. This is why urologists never diagnose off one test. If a result concerns you, repeat it after a few weeks under clean conditions before drawing any conclusion.
When Should You Skip Mail-In and Test in a Clinic?
At-home testing is a screening tool. It is good at getting you into the system and giving you a rough read. It is not the right choice for every situation.
Go to a clinic when the stakes are high. Fertility preservation before cancer treatment is the clearest case. If you are about to start chemotherapy, that stored sample may be your only future chance at biological children, and men in this situation often already have poor parameters because of the illness itself. Lamb was blunt about this: travel to bank your sperm, do not mail it. A mail-in kit cannot guarantee chain of custody, and years later, when you go to use a banked sample, you want certainty that the vial with your name on it is actually yours.
Go to a clinic when your mail-in result is abnormal. A low count or low TMSC from a shipped sample needs confirmation before it drives any treatment decision, especially given the algorithmic-correction concerns above.
A clinic is also the answer when you need parameters a home kit cannot measure. Standard mail-in tests report count, motility, and morphology. They do not assess sperm DNA fragmentation, anti-sperm antibodies, or the genetic factors a reproductive urologist can order. If you have been trying to conceive without success and your basic numbers look normal, those deeper tests are where the answer often lives.
That said, at-home testing has a genuine place. It works for post-vasectomy checks, where you mostly want to confirm the count is at or near zero and convenience improves compliance. It works as a first look for a man who would otherwise avoid the topic. And in rural areas with no urologist for hours in any direction, a mail-in kit may be the only realistic option. The wives, Lipshultz noted, often love the phone-based kits, because they get their partners engaged in the process at all. Getting tested imperfectly beats not getting tested.
What Does a Semen Analysis Tell You About Your Overall Health?
This is the part most men miss. Your semen analysis is not only a fertility test. It is one of the few routine windows into your long-term health, and the connection is strong enough that it should change how you think about the result.
Men with impaired semen quality carry a higher risk of a range of conditions, including cancer, cardiovascular and metabolic disease, and autoimmune disorders (Chen et al., 2022). A 2014 study in Human Reproduction, co-authored by Lamb and Lipshultz, followed men after infertility evaluation and found those with abnormal semen parameters had a higher risk of death in the following years, a link that held even after accounting for baseline health (Eisenberg et al., 2014). The relationship is dose-dependent: the more parameters that are abnormal, the steeper the risk.
The likely reason is that sperm production is biologically demanding and sensitive. The same processes that go wrong in the testis, mistakes in DNA replication and repair, can show up elsewhere in the body. Lamb described infertile men as sometimes carrying a "mutator phenotype," a tendency toward DNA copying errors that the testis is good at catching but other tissues are not.
So a low number is worth taking seriously beyond the immediate question of fatherhood. It is a prompt to look at the rest of your health. A 2024 review framed the male fertility evaluation as an opportunity to catch metabolic and cardiovascular problems early, while a man is still young enough to change the trajectory (Del Giudice et al., 2024). For men on TRT thinking about coming off to conceive, this is one more reason to treat the semen analysis as a real clinical checkpoint, not a box to tick.
Frequently Asked Questions
How accurate are mail-in semen tests compared to a clinic?
For sperm count and concentration, a good mail-in kit with preservation media is close to clinic accuracy and can be more consistent than testing across two different labs. Motility is the weak point, since it degrades during shipping, so a low motility or TMSC result should be confirmed in a clinic.How many days should I abstain before a semen test?
Two to seven days, per WHO guidance. Shorter than two days lowers your volume and count; longer than seven lowers motility and raises DNA fragmentation. The two-to-seven-day window gives the most reliable and repeatable numbers.Should I bank sperm by mail before chemotherapy?
No. Travel to a fertility clinic to bank sperm before cancer treatment. Mail-in kits cannot guarantee chain of custody, and a preservation sample before chemo may be your only future chance at biological children, so certainty matters more than convenience.Does one low semen analysis mean I am infertile?
No. Semen parameters vary widely within the same man from month to month, and an illness or poor collection can tank a single result. Urologists repeat the test before drawing any conclusion, and you should too.Can a semen test tell me anything about my general health?
Yes. Poor semen quality is linked to higher long-term risk of cancer, cardiovascular disease, metabolic disease, and mortality. An abnormal result is a reason to look at your broader health, not just your fertility.Related ExcelMale Forum Discussions
- The Present and Future of Male Fertility Testing - The Pearlman, Lipshultz, and Lamb discussion that inspired this article, covering collection errors and the future of genetic testing.
- Clinical Update on Home Testing for Male Fertility - A review of at-home kit technology and where these devices fall short.
- How Does hCG Prevent and Reverse Testicular Shrinkage on TRT? - Why blood testosterone can look perfect while the testicle is shut down, and how hCG protects fertility.
- When HCG is Added to TRT - Real member semen analysis results while running hCG alongside testosterone.
- Semen Analysis Results After Adding FSH to TRT and hCG - A documented member experiment showing how adding FSH moved his numbers over six months.
- How Men Can Use HCG With Testosterone to Improve Fertility, Libido and Testicular Size (Part 3) - Data on total motile count recovery after stopping testosterone and starting hCG.
- How to Induce Hyperspermia - A look at semen volume, why it varies, and what it does and does not tell you.
Key References
- Nelson K, et al. Validation of a mail-in delayed semen analysis protocol developed for home collection. F&S Reports, 2024. Redirecting
- Alexander U, Sakkas D, Arredondo F, Kteily K, Abou Ghayda R. Evaluating Semen Parameters for Predictive Correlations Between Fresh and Delayed Analysis Using an At-Home Semen Collection Kit. American Journal of Men's Health, 2025. https://doi.org/10.1177/15579883251401308
- Pomeroy K, Hickman C, Cooke S, Bertola R, Ramachandran A. Algorithmic adjustment of sperm motility in mail-in semen analysis causes diagnostic overfitting and systematic risk of clinical misclassification. Human Reproduction, 2026. https://doi.org/10.1093/humrep/deag083.321
- Eisenberg ML, Li S, Behr B, Cullen MR, Galusha D, Lamb DJ, Lipshultz LI. Semen quality, infertility and mortality in the USA. Human Reproduction, 2014. https://doi.org/10.1093/humrep/deu106
- Chen T, Belladelli F, Del Giudice F, Eisenberg ML. Male fertility as a marker for health. Reproductive BioMedicine Online, 2022. Redirecting
- Del Giudice F, et al. Male Fertility as a Proxy for Health. Journal of Clinical Medicine, 2024. https://doi.org/10.3390/jcm13185559
- Barbagallo F, et al. Ejaculatory abstinence duration impacts semen parameters: insights from a retrospective analysis on 23,527 analyses. Frontiers in Endocrinology, 2025. Frontiers | Ejaculatory abstinence duration impacts semen parameters: Insights from a retrospective analysis in male infertility on 23,527 analyses
- Hu G, et al. Association of abstinence time with semen quality in men undergoing fertility evaluation. Asian Journal of Andrology, 2022. https://doi.org/10.4103/aja202165
The Bottom Line for Your Next Test
One detail rarely makes it into the pitch for at-home kits: the sample you mail is a snapshot of what your body was doing about ten weeks ago, not today. Sperm take roughly 70 days to form, so a rough patch last winter can show up in this month's result long after you have recovered. That lag is exactly why a single number, mailed or in-clinic, is a starting point rather than a verdict. Use the mail-in test to get on the board, then confirm anything worrying with a urologist who can watch the trend and order what a kit cannot.
If you are on TRT and planning for fertility, the hCG and testicular protection guide is the next thing worth reading.
About ExcelMale
ExcelMale.com is one of the largest men's health communities online, with over 24,000 members and more than 20 years of archived discussions on testosterone replacement therapy, hormone optimization, fertility, and men's health. It was founded by Nelson Vergel, a chemical engineer, longtime patient advocate, and author of Testosterone: A Man's Guide and Beyond Testosterone.
Last edited by a moderator:
